Biotechnology News

July 21, 2014

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that a research paper which evaluated their surface technology was awarded...

July 21, 2014

ESSEN, Germany--(BUSINESS WIRE)--Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics‘ Flex® System

July 18, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Clinical results of patients treated with ConforMIS iTotal® customized knee implants presented at the 2014 International Congress for Joint Reconstruction (ICJR)

July 18, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Brainlab, a global leader in medical technology, announced today the release of ELEMENTS Automatic Brain Metastases Planning.

July 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the setup of a €10 million loan granted by its top shareholder...

July 18, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2014 financial results on Thursday, July 31, 2014 at 7:00 a.m. ET. Teva will host a conference call and live...

July 18, 2014

CINCINNATI--(BUSINESS WIRE)--Symplmed announced today that it has acquired U.S. rights to ACEON® (perindopril erbumine tablets), an angiotensin converting enzyme (ACE) inhibitor approved to treat patients with high blood pressure (hypertension)...

July 18, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended June 30, 2014. Second Quarter Results Sales for the quarter were approximately $1.52 billion, an...

July 18, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call...

July 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today that its President and CEO, Samuel Wagner, was interviewed by CEOCFO Magazine, a weekly industry publication that conducts in depth interviews with corporate executives. The interview...

July 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics, Inc., a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, announced the pricing of its IPO.

July 17, 2014

WASHINGTON--(BUSINESS WIRE)--Because of the environmental, economical and societal benefits they provide, genetically engineered (GE) varieties of soybeans, cotton and corn are the preferred choice of U.S. farmers according USDA.

July 17, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--DesignMedix, Inc., a biotech company that develops drugs to overcome drug resistance, has closed a second, $1.5 million round of angel funding from investors in the Northwest.

July 17, 2014

WASHINGTON--(BUSINESS WIRE)--Programming at BIO's Livestock Biotech Summit will address new methods for ensuring optimal care and use of agricultural animals for a range of applications. The 2014 Summit will be held in September.

July 17, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 11, 2014. Management will hold a conference call to...

July 17, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals announced the results of voting at its 2014 Annual Meeting of Stockholders (the Annual Meeting) held July 17, 2014.

July 17, 2014

TORRANCE, Calif.--(BUSINESS WIRE)--Phenomenex Inc. will spin off a company named Neoteryx LLC to deliver novel microsampling products that provide less invasive, simpler solutions for collecting and testing biological samples.

July 17, 2014

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Synergy Biomedical announces expanded FDA clearance of BioSphere Putty for spine indications.

July 17, 2014

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular Announces Patent Allowance for Dengue Research Technology

July 17, 2014

NEWTON, Mass. & AUDUBON, Pa.--(BUSINESS WIRE)--TrialNetworks Charting analyzes data from integrated clinical systems to provide study teams with dynamic charts displaying performance metrics and progress toward goals by region, country and...

July 17, 2014

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced the opening of its new 91,440-square-meter facility near Ho Chi Minh City, Vietnam.

July 17, 2014

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that the U.S. Patent and Trademark Office...

July 17, 2014

WASHINGTON--(BUSINESS WIRE)--On July 16, 2014, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz, joined by pro-taxpayer groups FreedomWorks and Taxpayers for Common Sense, and the non-profit public policy group...

July 17, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announces today the decision of the Board of...

July 17, 2014

PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard reports 1H 2014 revenues €2.1 million
Company accelerates the development of its Smart Screw

July 17, 2014

BETHESDA, Md.--(BUSINESS WIRE)--Evidera, a global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, has announced the addition of Xavier Badia, M.D., M.P.H., Ph.D.

July 17, 2014

BIRMINGHAM, England & SAN DIEGO--(BUSINESS WIRE)--Freelite® and Hevylite® from Binding Site will help the Black Swan Research Initiative® find the best treatment to cure multiple myeloma

July 17, 2014

MINNEAPOLIS--(BUSINESS WIRE)--Blue Belt Technologies has received FDA clearance to market their latest surgical application for the Navio® Surgical System, patellofemoral joint (PFJ) replacement surgery. The PFJ application expands the Navio...

July 17, 2014

LOUISVILLE, Ky.--(BUSINESS WIRE)--PGXL Laboratories has received regulatory authorization to conduct clinical trials of its PerMIT:Warfarin companion informatics software. This favorable administrative decision allows PGXL to enroll up to 720...

July 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems, Inc., (7SBio), a leading developer of blood collection and diagnostic platforms, announced today the receipt of notices of allowance from the United States Patent and Trademark Office...

July 17, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corp.'s LogPad System is a finalist for MassTLC 2014 Healthcare & Life Sciences Innovation Award. PHT is the leading provider of technologies to collect patient-driven eData for clinical research.

July 17, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN) will release its second quarter 2014 financial results before the market opens on July 24, 2014. Agenus executives will host a conference call at 11:00 a.m. Eastern Time that same day...

July 17, 2014

CHICAGO--(BUSINESS WIRE)--GTCR, a leading private equity firm, today announced that it has entered into a definitive agreement to acquire the Cole-Parmer Instrument Company (“Cole-Parmer”) from Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo...

July 17, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC...

July 17, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a clinical-stage biotechnology company, today announced that renowned academic leader and industry veteran, Gerald Chan, DSc has joined its board of directors. Dr. Chan is the co-founder of...

July 17, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) today announced that Sri Lanka’s Ministry of Health has cleared the Company to commence patient enrollment for its Phase III Head and Neck Cancer clinical trial of its...

July 17, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that it has submitted the third and final module for its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA), for review of the...

July 17, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, July 31 2014, after the close of the stock market. The company will host a conference call and webcast...

July 17, 2014

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE) is pleased to announce the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized...

July 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-inducible factor (HIF) biology to develop and commercialize novel therapeutics to treat kidney...

July 17, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced the initiation of a phase 1 clinical study of ALKS 8700, a novel monomethyl fumarate (MMF) molecule in development for the treatment of multiple sclerosis (MS). The randomized,...

July 17, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today reported strong growth across its global franchises in the second quarter, generating sales and earnings that exceeded the company’s previously issued guidance. The...

July 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that it has received final approval from the New York State Department of Health for FoundationOne® and FoundationOne Heme®. These fully informative genomic...

July 17, 2014

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics is proud to be a national sponsor of the NOCC 2014 Run/Walk to Break the Silence on Ovarian Cancer. In addition to sponsoring their local Pittsburgh Chapter event, Precision will be present at...

July 17, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Completes Patient Enrollment for its SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation